Back
Pliant Therapeutics Stock Price Chart
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Buy
60
PLRX
Pliant Therapeutics
Last Price:
14.64
Seasonality Move:
0.26%
7 Day Trial
ALL ACCESS PASS
$
7
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLRX is experiencing slight selling pressure.
Pliant Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.51 | Buy |
| 20-day SMA: | 13.11 | Buy |
| 50-day SMA: | 12.77 | Buy |
| 200-day SMA: | 13.68 | Buy |
| 8-day EMA: | 14.33 | Buy |
| 20-day EMA: | 13.57 | Buy |
| 50-day EMA: | 12.96 | Buy |
| 200-day EMA: | 13.75 | Buy |
Pliant Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.69 | Buy |
| Relative Strength Index (14 RSI): | 61.83 | Buy |
| Chaikin Money Flow: | -6991 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.11 - 14.37) | Buy |
| Bollinger Bands (100): | (11.21 - 13.63) | Buy |
Pliant Therapeutics Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Pliant Therapeutics Stock
Is Pliant Therapeutics Stock a Buy?
- Pliant Therapeutics share price is 14.72 while PLRX 8-day simple moving average is 14.51, which is a Buy signal.
- The stock price of PLRX is 14.72 while Pliant Therapeutics 20-day SMA is 13.11, which makes it a Buy.
- Pliant Therapeutics 50-day simple moving average is 12.77 while PLRX share price is 14.72, making it a Buy technically.
- PLRX stock price is 14.72 and Pliant Therapeutics 200-day simple moving average is 13.68, creating a Buy signal.
PLRX Technical Analysis vs Fundamental Analysis
Buy
60
Pliant Therapeutics (PLRX)
is a Buy
Is Pliant Therapeutics a Buy or a Sell?
-
Pliant Therapeutics stock is rated a Buy
The current Pliant Therapeutics [PLRX] share price is $14.72. The Score for PLRX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Pliant Therapeutics Stock Info
Market Cap:
895M
Price in USD:
14.72
Share Volume:
321.58K
Pliant Therapeutics 52-Week Range
52-Week High:
19.62
52-Week Low:
10.22
Buy
60
Pliant Therapeutics (PLRX)
is a Buy
Pliant Therapeutics Share Price Forecast
-
What is the Pliant Therapeutics stock price today?
The Pliant Therapeutics stock price is 14.72 USD today. -
Will PLRX stock go up or go down?
Pliant Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Pliant Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pliant Therapeutics is not overvalued.
Is Pliant Therapeutics Stock a Buy?
- Pliant Therapeutics share price is 14.72 while PLRX 8-day exponential moving average is 14.33, which is a Buy signal.
- The stock price of PLRX is 14.72 while Pliant Therapeutics 20-day EMA is 13.57, which makes it a Buy.
- Pliant Therapeutics 50-day exponential moving average is 12.96 while PLRX share price is 14.72, making it a Buy technically.
- PLRX stock price is 14.72 and Pliant Therapeutics 200-day simple moving average is 13.75, creating a Buy signal.
Fundamental Analysis of Pliant Therapeutics
Is Pliant Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.32 per share.
Technical Analysis of Pliant Therapeutics
Should I short Pliant Therapeutics stock?
- PLRX Moving Average Covergence Divergence (MACD) indicator is 0.69, suggesting Pliant Therapeutics is a Buy
- Pliant Therapeutics Relative Strength Index (RSI) is 61.83, which suggest Pliant Therapeutics is overbought
- The Bollinger Bands (25) for Pliant Therapeutics is (11.11 - 14.37), which suggest Pliant Therapeutics is a Buy
- The Bollinger Bands (100) for Pliant Therapeutics is (11.21 - 13.63), which suggest Pliant Therapeutics is a Buy
* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.